Beranda › Diabetes Tipe 1 › Washington
Uji klinis Diabetes Tipe 1 di Washington
20 studi untuk Diabetes Tipe 1 mencari peserta di lokasi di Washington.
Kota di Washington
Teks studi resmi (Bahasa Inggris)
Type 1 Diabetes Extension Study
- Benaroya Research Institute, Seattle
Menerima pesertaStudi observasional
Usia 8 hingga 35 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Menerima pesertaFase 2
Usia 18 hingga 69 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07699380A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
- MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma
Menerima pesertaFase 3
Usia 1 hingga 25 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
Menerima pesertaFase 1/2
Usia 12 hingga 35 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Benaroya Research Institute, Seattle
Menerima pesertaFase 2
Usia 4 hingga 34 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Benaroya Research Institute, Seattle
Menerima pesertaFase 2
Usia 8 hingga 45 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Seattle Children's Hospital, Seattle
Menerima pesertaFase 1/2
Usia 9 hingga 20 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07061574SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason, Seattle
- Mary Bridge Children's Outpatient Center - Tacoma, Tacoma
Menerima pesertaFase 2
Usia 5 hingga 40 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Washington, Seattle
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT06880835Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT05822609Kidney Precision Medicine Project
- University of Washington, Seattle
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Apr 2026 · NCT04334707Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
- Rainier Clinical Reseach Center, Renton
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT07296276Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Rainier Clinical Research Center, Renton
Menerima pesertaFase 2
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 6 Apr 2026 · NCT06964087Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT06217302Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Menerima pesertaFase 3
Usia 18 hingga 49 · Semua jenis kelamin · Diperbarui 4 Mar 2026 · NCT05819138Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
- Seattle Children's, Seattle
Menerima peserta
Usia 16 hingga 19 · Semua jenis kelamin · Diperbarui 30 Des 2025 · NCT07292558EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Benaroya Research Institute, Seattle
Menerima pesertaStudi observasional
Hingga usia 70 · Semua jenis kelamin · Diperbarui 19 Des 2025 · NCT03369821InvesT1D: Promoting Adolescent Investment in Diabetes Care
- Seattle Children's, Seattle
Menerima peserta
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 16 Des 2025 · NCT06384911TrialNet Pathway to Prevention of T1D
- Benaroya Research Institute, Seattle
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 45 · Semua jenis kelamin · Diperbarui 1 Jul 2025 · NCT00097292MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
Menerima pesertaFase 1
Usia 12 hingga 25 · Semua jenis kelamin · Diperbarui 13 Jun 2025 · NCT05065372Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.